ACTIVE SUBSTANCE / INN

BECLOMETHASONE DIPROPIONATE

Brand name(s): QVAR 40, orBec, VANCENASE, BECONASE, VANCERIL DOUBLE STRENGTH, VANCERIL, BECLOVENT, BECLOMETHASONE DIPROPIONATE, QVAR 80, QVAR REDIHALER, QNASL
FDA LISTED
EMA LISTED
PRESCRIPTION
APPLICATION WITHDRAWN
DISCONTINUED
NDA020486
NDA018153
ACTIVE SUBSTANCE
Beclomethasone Dipropionate
REGULATORS
FDA · EMA
SPONSORS / MAH
TEVA BRANDED PHARM, GLAXOSMITHKLINE, NORTON WATERFORD
TOTAL APPLICATIONS
11
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
BECLOVENTNDA018153GLAXOSMITHKLINEDiscontinued
QNASLNDA202813TEVA BRANDED PHARMPrescription
VANCERIL DOUBLE STRENGTHNDA020486SCHERINGDiscontinued
VANCERILNDA017573SCHERINGDiscontinued
QVAR 80NDA020911TEVA BRANDED PHARMDiscontinued
QVAR 40NDA020911TEVA BRANDED PHARMDiscontinued
VANCENASENDA018521SCHERINGDiscontinued
BECONASENDA018584GLAXOSMITHKLINEDiscontinued
QVAR REDIHALERNDA207921NORTON WATERFORDPrescription
BECLOMETHASONE DIPROPIONATEANDA213811AMNEAL IRELAND LTDPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
orBecDOR BIOPHARMA UK LtdApplication withdrawnGraft vs Host Disease

FULL INTELLIGENCE ON BECLOMETHASONE DIPROPIONATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →